Navigation Links
CryoCor Reports 2007 Results
Date:3/20/2008

ssfully commercialized, they anticipate that their cost of sales as a percentage of revenues will decline as they achieve higher future volumes of product sales. Included in cost of sales for the years ended December 31, 2007 and 2006 were non-cash stock-based compensation of $431,000 and $411,000, respectively.

Research and development expenses for the year ended December 31, 2007 increased $1.6 million to $7.4 million compared to $5.8 million for the same period in 2006. The increase from 2006 to 2007 was primarily related to the costs associated with its FDA Advisory Panel meeting for its PMA for the treatment of atrial flutter, or AFL, and related regulatory consulting of $276,000, costs related to the Company's third-party clinical research organization of $403,000, costs related to the research and development efforts under the BSC development and license agreement and the Quantum development project of $382,000, increased preclinical research of $225,000, increased non-cash share-based compensation of $185,000, as well as increased compensation expense for bonus expense related to the Company's FDA Advisory Panel meeting and subsequent approval of its Cardiac Cryoablation System for the treatment of AFL and the Company's employee retention program of $503,000. These increases were partially offset by lower clinical trial costs of $261,000 related to lower enrollment in the Company's ongoing AF clinical trial than enrollment in the year ended December 31, 2006. Included in research and development expenses for the years ended December 31, 2007 and 2006 were non-cash stock-based compensation of $682,000 and $497,000, respectively.

Selling, general and administrative expenses for the year ended December 31, 2007 decreased $1.3 million to $6.1 million compared to $7.4 million for the same period in 2006. The decrease from 2006 to 2007 was primarily due to lower personnel costs, including severance, as a result of the Company's staff restructuring in
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. CryoCor Announces Web cast and Conference Call of 2007 Year End Results
2. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
3. Dr. Warren Jackman Joins CryoCor Scientific Advisory Board
4. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
5. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
6. CryoCor Files Response to Patent Infringement Lawsuit
7. CryoCor Announces Web cast and Conference Call of Third Quarter 2007 Results
8. CryoCor Appoints New Vice President of Sales and Marketing
9. CryoCor to Present at Maxim Group First Annual Growth Conference in New York
10. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
11. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... (PRWEB) July 29, 2014 Launched in ... Heaven surpassed 20,000 hangovers earlier this year at ... prepares for expansion and the publication of research data ... the medical practice. , The only licensed medical practice ... Hangover Heaven launched in 2012 and treated thousands of ...
(Date:7/29/2014)... brides want their bridal dresses and bridal parties to ... sure to provide designs of wedding gowns and bridesmaids ... has recently announced its new collection of gorgeous lace ... come with big savings, up to 61% off. , ... working in the garment industry for several years; they ...
(Date:7/28/2014)... are gluttons. We have long known that they monopolize ... that some tumor cells are also characterized by a ... join in an ordered set. Researchers are calling this ... At EPFL, Etienne Meylan,s research team was able to ... and mesenchymal behavior result from the same mechanism, ...
(Date:7/28/2014)... “China Surgical Generators Market Outlook to ... Surgical Generators market. The report provides value, in ... average prices (in US dollars) within market segments ... Argon Plasma Coagulation Generators. , The report also ... each of these market categories, and global corporate-level ...
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading ... the release of the fourth edition of The Brain ... Underwood. , The Brain Health Guide is a unique ... readers to improve memory and promote optimal aging. Rather ... Health Guide provides ways to help minimize common memory ...
Breaking Medicine News(10 mins):Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3Health News:LunaDress’ Summer Sale Has Arrived: All Its Gorgeous Lace Wedding Dresses are Affordable Now 2Health News:Cancer: Tumors absorb sugar for mobility 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 3Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 4Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2
... ... We are pleased to announce the launch of Anianet, a free ... the Chinese academic market has continued to explode (there are now ... three times more engineering PH.D.,s annually than the United States), China,s ...
... ... http://www.youmeandtea.com , ... NY (PRWEB) -- You, Me and Tea is pleased to announce the launch of their new ... India, China, and Sri Lanka and specializes in the retailing of India,s world-renowned teas (Darjeeling, Assam ...
... ... Follicular Unit Extraction (FUE) hair restoration office using NeoGraft™. Automated FUE ... does not require scalpels, sutures, staples, and leaves no scars on the ... brings to Orange County and Southern California, a fully equipped and trained ...
... Quality ... ... Associates, Inc. today announced a broad partnership with Health Management Associates , Inc. (NYSE:HMA) ... started working with HMA on October 1, 2009. , , , , ,HMA owns and ...
... 15 As the 2010 Dietary Guidelines for ... sodium consumption are being considered, an analysis of evidence ... the American Society of Nephrology (CJASN) questions the ... limit salt intake in humans. , After examining ...
... The 2009 Cumulative Supplement to ... legal developments in pharmaceutical patent law. Published by ... , Pharmaceutical Patent Law is supplemented annually ... implications of patent settlements; the experimental use privilege; and international ...
Cached Medicine News:Health News:New Professional Network Brings Chinese Scientists and Researchers into International Community 2Health News:New Professional Network Brings Chinese Scientists and Researchers into International Community 3Health News:New Professional Network Brings Chinese Scientists and Researchers into International Community 4Health News:You, Me and Tea is Pleased to Announce the Website Debut of youmeandtea.com 2Health News:New NeoGraft Hair Restoration Now Available in Orange County, California 2Health News:New NeoGraft Hair Restoration Now Available in Orange County, California 3Health News:New NeoGraft Hair Restoration Now Available in Orange County, California 4Health News:Press Ganey Partners With Health Management Associates 2Health News:New Evidence Shakes Up Perceptions of Salt 2Health News:New Evidence Shakes Up Perceptions of Salt 3Health News:New Evidence Shakes Up Perceptions of Salt 4Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 2Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 3
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore e pioniere ... respiratori del sonno (SDB) e altre patologie croniche del ... il produttore Taiwanese di dispositivi medicali, APEX Medical Corp. ... in testa, che violano i brevetti, utilizzate con l,APEX ... Corte Regionale Distrettuale di Monaco , ...
(Date:7/28/2014)... 28, 2014  ResMed (NYSE: RMD ), ... treatment of sleep-disordered breathing and other chronic respiratory conditions, ... against Taiwanese medical device manufacturer APEX Medical ... APEX WiZARD 210 and 220 masks.  The judgment was ... Munich , is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... England , July 28, 2014 /PRNewswire/ ... dass Albion Ventures 2,5 Millionen £ investiert ... in der Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche ... Ventures.      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ... 18 Monaten hat OmPrompt sein beschleunigtes Wachstum ...
Breaking Medicine Technology:ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: